Sysmex Inostics
|
Year Established:
2008 |
|
|
Website:
sysmex-inostics.com |
|
|
Headquarters:
Baltimore, MD, US |
|
|
Company Type:
Mid-Sized Business (10-100M TTM Revenue) |
|
|
Professional Associates:
BIOCOM |
Sysmex Inostics, a subsidiary of Sysmex Corporation, is a global leader in liquid biopsy clinical testing committed to improving the lives of patients with cancer. Our pioneering technologies, such as the gold-standard OncoBEAM (BEAMing) digital PCR and NGS-based SafeSEQ, deliver unparalleled high sensitivity for detection of tumor molecular alterations in blood and other sample types. We are a trusted partner to leading pharmaceutical companies, advancing their efforts to bring the most effective personalized cancer therapies and solutions to global markets.
Sysmex Inostics´ three main areas of focus are:
• BioPharma liquid biopsy testing & services
• CDx/IVD development
• Patient testing services (US only)
Our Capabilities:
• Custom Biomarker Assay Development
• Global footprint of GCP/CLIA certified laboratories
• Analytical and Clinical Validation
• Global Regulatory Registration/Approval
• cGMP Manufacturing
• Full Service Clinical Trial Project Management
• Companion Diagnostic (CDx) Kit Development and Commercialization
| Site | Badges | |
|---|---|---|
| Sysmex Inostics, Inc. 1812 Ashland Avenue Baltimore, MD, 21205 United States | ||
| Sysmex Inostics GmbH Falkenried 88 Hamburg, , 20251 Germany | ||
| Sysmex Inostics Kōbe-shi, Hyōgo-ken, 651-2241 Japan | ||
| Sysmex Inostics 88 Falkenried Hamburg, HH, 20251 Germany | ||
| Sysmex Inostics 1812 Ashland Avenue Baltimore, MD, 21205 United States | ||
Get started
If your organization has a Scientist.com marketplace, you can log in here to order products and services directly. If you're interested in ordering custom research services from suppliers in the Scientist.com network, book a meeting with our team here. To order products instantly, request access below.